Prognostic factors and outcome of relapsed/progressive pediatric Ewing sarcoma: single-center 10-year experience
Patients with relapsing/progressive ES portended a poor outcome, with disease progression on treatment faring worse than relapse. Better outcome was observed in patients who experienced recurrence > 2 years after diagnosis, patients with disease recurrence rather than disease progression on treatment, and patients who underwent local control along with intensive chemotherapy.
Authors
- Moatasem El Ayadi
- Omar Arafah (ORCID: https://orcid.org/0000-0002-1509-7525)
- Azza Nasr
- Mohamed Fawzy
- Reem Ragab Hegazy
Institutions
- Cairo University (EG)
- National Water Research Center (EG)
- Children Cancer Hospital (EG)
Publication Details
- Journal
- Journal of the Egyptian National Cancer Institute
- Published
- 2024-08-19
- DOI
- https://doi.org/10.1186/s43046-024-00232-4
- Citations
- 4
- Primary Topic
- Sarcoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.68